The first option would require coercion, and – since countries will not accept that others should gain a competitive edge – an international agreement to forego the benefits that genetic enhancement can bring. The second option, universal access, would require an unprecedented level of social assistance for the poor, and extraordinarily difficult decisions about what to subsidize.